Peer Review History: Prevention of the Development of Chronic Diseases in the Era of the COVID-19 Pandemic: A Systematic Review

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

(2) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Omaima Mohamed Elalem, Port Said University, Egypt.

(2) Md Abdur Razzak, Delaware Biotechnology institute, University of Delaware, USA.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Omaima Mohamed Elalem, Egypt) | File 1 | NA


Stage 2 | Peer review report_2 (Md Abdur Razzak, USA) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


 

Peer Review History: The Outpatient Use of Ascorbic Acid in a Public Healthcare Organization in Riyadh Region

Editor(s):

(1) Dr. Asmaa Fathi Moustafa Hamouda, Assistant Professor,  Jazan University, Saudi Arabia.

Reviewers:

(1) Zahoor Ahmad Sajid, University of the Punjab, Pakistan.

(2) Naga Ravi Kiran Tangirala, Narasaraopeta Institute of Pharmaceutical Sciences, India.

Additional Reviewers:

(1) Ashish Maruti Shendurse, Kamdhenu University, India.

(2) Ifora ifora, School of Pharmaceutical Science, Indonesia.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Zahoor Ahmad Sajid, Pakistan) | File 1 | NA


Stage 2 | Peer review report_2 (Naga Ravi Kiran Tangirala, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA

Peer Review History: Awareness of Parents Regarding DKA Symptoms in their Children with Type I DM

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.

Reviewers:

(1) Joan-Antoni Valles, UdG, Spain.

(2) Akanksha Tomar, NSCB Medical College Jabalpur, India.

(3) Takahiko Nagamine, Sunlight Brain Research Center, Japan.

Additional Reviewers:

(1) Dominic Worku, United Kingdom.

(2) Dharmendra Panchal, Gujarat University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Joan-Antoni Valles, Spain) | File 1 | File 2


Stage 2 | Peer review report_2 (Akanksha Tomar, India) | File 1 | NA


Stage 2 | Peer review report_3 (Takahiko Nagamine, Japan) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Saudi Population Awareness Regrading Methods of Colorectal Cancer Screening

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.

Reviewers:

(1) Zheng Liu, Peking Medical College, China.

(2) Mahbuba Sharmin, Bangabandhu Sheik Mujib Medical University, Bangladesh.

Additional Reviewers:

(1) Fevzi Cengiz, Tinaztepe University, Turkey.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Zheng Liu, China) | File 1 | NA


Stage 2 | Peer review report_2 (Mahbuba Sharmin, Bangladesh) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: DNA Extraction and Quantification of Some Economically Important Fruits in Tamil Nadu

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

Reviewers:

(1) Muhammad Miandad, University of Gujrat, Pakistan.

(2) Devaraj Chandrashekar, Chapman University, USA.

Additional Reviewers:

(1) G. Nageswara Rao, Andhra University, India.

(2) Harish M, SCMS Institute of Bioscience & Biotechnology Research & Developement, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Muhammad Miandad, Pakistan) | File 1 | NA


Stage 2 | Peer review report_2 (Devaraj Chandrashekar, USA) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Awareness and Knowledge of the Adult Population in Saudi Arabia on Teeth Discoloration and Treatment Options: A Cross-Sectional Study

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

Reviewers:

(1) Rachna Jain, India.

(2) Shaik Mohammed Asif, King Khalid University, Saudi Arabia.

Additional Reviewers:

(1) Maryam Zahed, Shiraz University of Medical Sciences, Iran.

(2) Mohnish Muchhal, Subharti Dental College, India.

(3) Smriti Golhar, VSPMDCRC. MUHS Nashik University, India

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Rachna Jain, India) | File 1 | NA


Stage 2 | Peer review report_2 (Shaik Mohammed Asif, Saudi Arabia) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Formulation Development and Evaluation of Doxofylline Sustained-Release Tablets by Using Chitosan and Guar Gum

Editor(s):

(1) Dr. Rafik Karaman, Professor, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Afewerk Getachew, Mekelle University,Ethiopia.

(2) Akinde Kehinde Yemisi, Ekiti State University, Nigeria.

(3) Ilochi Ogadinma, Madonna University, Nigeria.

Additional Reviewers:

(1) Prakash Katakam, Indira College of Pharmacy, India.

(2) Sakina Salem Saadawi, University of Tripoli, Libya.

(3) Abikesh Prasada Kumar Mahapatra, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Afewerk Getachew, Ethiopia) | File 1 | File 2


Stage 2 | Peer review report_2 (Akinde Kehinde Yemisi, Nigeria) | File 1 | File 2


Stage 2 | Peer review report_3 (Ilochi Ogadinma, Nigeria) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


 

Peer Review History: Case Report: Management and Outcomes of COVID-19 in a Patient with Cirrhosis of Liver

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Reviewers:

(1) S. Lokesh, ICMR-National Institute of Epidemiology, India.

(2) D.S.Pushparani, Dg Vaishnav College, India.

(3) Sheikh Shahnawaz, India.

(4) Lucaci Corina, Regina Maria Hospital, Romania.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (S. Lokesh, India) | File 1 | NA


Stage 2 | Peer review report_2 (D.S.Pushparani, India) | File 1 | File 2


Stage 2 | Peer review report_3 (Sheikh Shahnawaz, India) | File 1 | NA


Stage 2 | Peer review report_4 (Lucaci Corina, Romania) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


 

Peer Review History: New Validation of COVID-19’s effects on Micro, small and Medium Enterprise and Its Survival

Editor(s):

(1) Dr. Fang Xiang, Visiting Professor, International Business School, University of International and Business Economics, China.

(2) Dr. Chun-Chien Kuo, Associate Professor, National Taipei University of Business, Taiwan.

Reviewers:

(1) James Baariu Mungiria, Kenyatta University, Kenya.

(2) Sushil Kumar Pradhan, Srusti Academy of Management, India.

(3) Teddy Hikmat Fauzi, Universitas Pasundan Bandung, Indonesia.

Additional Reviewers:

(1) Lydie Myriam Marcelle Amelot, University of Mauritius, Mauritius.

(2) Uket Ewa, ross River University of Technology, Nigeria.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.2/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (James Baariu Mungiria, Kenya) | File 1 | NA


Stage 2 | Peer review report_2 (Sushil Kumar Pradhan, India) | File 1 |NA


Stage 2 | Peer review report_3 (Teddy Hikmat Fauzi, Indonesia) | File 1 |NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


 

Peer Review History: Virgin Olive Oil and Its Use in Gastronomic Offer of Dalmatia and Istria

Editor(s):

(1) Dr. Rasha Mousa Ahmed Mousa, University of Jeddah, Saudi Arabia.

Reviewers:

(1) Zoe Mousia, Greece.

(2) Emilija Friganović, Marko Marulić Polytechnic of Knin, Croatia.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.8/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Zoe Mousia, Greece) | File 1 | NA


Stage 2 | Peer review report_2 (Emilija Friganović, Croatia) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA